Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vicacom
- Development stage
- Unknown
- Lead developer
- ICA
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Vicacom is an oral fixed-dose combination product developed and marketed by ICA Pharmaceuticals (ICA Biotechnological & Pharmaceutical) in Vietnam. It is formulated as a capsule containing sodium chondroitin sulfate, retinol palmitate (vitamin A), choline hydrogen tartrate, riboflavin (vitamin B2), and thiamine hydrochloride (vitamin B1). Vicacom is indicated for the treatment of eye fatigue, keratitis, ophthalmoplegia, amblyopia during lactation, nyctalopia (night blindness), and as a nutritional supplement for decreased vision. The combination works synergistically to support ocular health: sodium chondroitin sulfate stabilizes the intracellular collagen of ocular muscles and maintains corneal transparency, while the vitamins and choline support epithelial tissue maintenance, protect the cornea, and prevent eye aging.
- Brand names
- TobicomVicacom
- Other names
- choline hydrogen tartrate + retinol palmitate + riboflavin + sodium chondroitin sulfate + thiamine hydrochloride
02
Targets
RARA (Retinoic acid receptor alpha)RARB (Retinoic acid receptor beta)RARG (Retinoic acid receptor gamma)
Beyond the preview
Go deeper on Vicacom.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vicacom.